While glucagon-like peptide-1 (GLP-1) agonists have not been widely attempted in DS and have shown mixed benefit for PBH, combination GLP-1 and gastric inhibitory peptide agonism may represent a novel treatment both for PBH and DS, providing greater improvement in glycemic variation as well as better DS control than GLP-1 agonism alone
His claim about muscle sparing is more nuanced than he suggested DXA data shows the fat-to-lean loss ratio is similar to other GLP-1 drugs, not uniquely better
This simple method makes it easier for more patients to follow their treatment plan
During her initial consultation, her weight was 109 kg, her height was 146.5 cm, and her BMI was 50.8 kg/m 2
Always ask your doctor before starting berberine if youre also taking prescription drugs
Saldanha G, Purnell D, Fletcher A, et al